Bovine Colostrum 관련 Traveler's Diarrhea
BHyperimmune bovine colostrum (containing anti-ETEC antibodies) reduces traveler's diarrhea incidence. IgG antibodies provide passive immunity against E. coli toxins.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dbovine\u002Dcolostrum\u0026condition\u003Dtravelers\u002Ddiarrhea';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
결론
Hyperimmune bovine colostrum (containing anti-ETEC antibodies) reduces traveler's diarrhea incidence. IgG antibodies provide passive immunity against E. coli toxins.
Key Study Findings
Controlled Clinical Trial
n=18
4 weeks
The effect of adding colostrum or sodium butyrate to the diet on the intestinal barrier …
Dose: None
vs: control (no additive)
Outcome: intestinal barrier function and growth performance
효과: None
p<0.001
대상 집단: weaned DanBred Hybrid piglets aged 28 days
Review
Clinical Applications of Bovine Colostrum in GastrointestinaI Disorders: Mechanisms, Evidence, and Therapeutic Potential.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Review
Exploiting the vulnerability of SARS-CoV-2 with a partnership of mucosal immune function and nutrition: a …
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Meta-Analysis
Bovine Colostrum in Increased Intestinal Permeability in Healthy Athletes and Patients: A Meta-Analysis of Randomized …
Dose: None
vs: Control
Outcome: Inflammatory markers
효과: MD: -0.01
None
대상 집단: None
Randomized Controlled Trial
n=65
10 weeks
Evaluation of bovine colostrum replacer supplementation to improve weaning transition in Holstein dairy calves.
Dose: Bovine colostrum replacer during weaning
vs: No colostrum supplementation
Outcome: Intestinal permeability and weight gain
효과: None
None
대상 집단: Holstein dairy calves during weaning
In Vitro
Understanding the Immunomodulatory Effects of Bovine Colostrum: Insights into IL-6/IL-10 Axis-Mediated Inflammatory Control.
Dose: None
vs: None
Outcome: Cytokine production (IL-6/IL-10 axis)
효과: None
p < 0.05
대상 집단: In vitro (Caco-2/THP-1 co-culture model)
Key Statistics
3
연구
400
참여자
↑
Positive
B
등급
Referenced Papers
PloS one
2026
International journal of …
2025
Nutrition research reviews
2025
Digestive diseases and …
2024
4 인용
Journal of dairy …
2024
1 인용
Veterinary sciences
2023
9 인용
Veterinary sciences
2023
7 인용
A Systematic Review of the Influence of Bovine Colostrum Supplementation on Leaky Gut Syndrome in Athletes: Diagnostic Biomarkers and Future …
Systematic Review
Nutrients
2022
11 인용
Biomedicines
2022
7 인용
Nutrients
2021
26 인용
Medicine
2021
2 인용
Frontiers in immunology
2020
24 인용
Medicina (Kaunas, Lithuania)
2020
18 인용
European journal of …
2019
42 인용
Nutrition (Burbank, Los …
2019
37 인용
European journal of …
2017
93 인용
Nutrients
2017
49 인용
The American journal …
2016
75 인용
American journal of …
2016
15 인용
American journal of …
2015
85 인용
Journal of animal …
2014
15 인용
American journal of …
2011
161 인용
Nutrients
2009
30 인용
Journal of medicinal …
2009
25 인용
Journal of the …
2009
24 인용
Alimentary pharmacology & …
2006
181 인용
Clinical nutrition (Edinburgh, …
2005
43 인용
Asia Pacific journal …
2005
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 10-20 g/day
- travelersdiarrhea:
- Hyperimmune colostrum: 400-3,600 mg/day (anti-ETEC formulation)
- exercisegutprotection:
- 20 g/day starting 14 days before intense exercise
- intestinalpermeability:
- 20-60 g/day for gut barrier support
상한량: No established upper limit; most studies use 10-60 g/day
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | 4 weeks | Positive | 18 |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| Bovine colostrum replacer during weaning | 10 weeks | Positive | 65 |
| None | -- | Positive | -- |
| 2.5% | 5.0 weeks | Mixed | 13 |
| None | -- | Positive | -- |
권장 복용 시간: On an empty stomach (30 minutes before meals) for gut barrier support
Safety & Side Effects
보고된 부작용
- ⚠ Mild GI discomfort (bloating, nausea) during initial use
- ⚠ Not suitable for individuals with cow's milk protein allergy
- ⚠ Lactose content may affect lactose-intolerant individuals
- ⚠ Potential concern about growth factor (IGF-1) content in cancer survivors (theoretical)
알려진 상호작용
- ● Immunosuppressants (colostrum immunoglobulins may theoretically interfere; clinical significance unclear)
- ● No significant adverse drug interactions established
일일 최대 섭취 허용량: No established upper limit; most studies use 10-60 g/day
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Bovine Colostrum help with Traveler's Diarrhea?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bovine Colostrum may support Traveler's Diarrhea management. Our evidence grade is B (Good Evidence).
How much Bovine Colostrum should I take for Traveler's Diarrhea?
Studies have used various dosages. A commonly studied range is 10-20 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bovine Colostrum?
Reported side effects may include Mild GI discomfort (bloating, nausea) during initial use, Not suitable for individuals with cow's milk protein allergy, Lactose content may affect lactose-intolerant individuals, Potential concern about growth factor (IGF-1) content in cancer survivors (theoretical). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bovine Colostrum and Traveler's Diarrhea?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.
Related Evidence
관련 다른 성분: Traveler's Diarrhea
Bovine Colostrum 다른 건강 상태에 대한 근거
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.